ArticleFrontiers in pediatrics2022

Case Report: Mucopolysaccharidosis Type I Treatment With α-L-Iduronidase Replacement Therapy.

Ying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.